Group 1: No T2DM, no prior CVD (n = 33,091) | Group 2: No T2DM, prior CVD (n = 9,991) | Group 3: T2DM, no prior CVD (n = 7,470) | Group 4: T2DM, prior CVD (n = 3,382) | p value | p value (for comparison between group 2 and 3) | p value (for comparison between group 3 and 4) | |
---|---|---|---|---|---|---|---|
All-cause mortality, n (%) | 9,183 (27.8) | 3,385 (33.9) | 2,318 (31.0) | 1,360 (40.2) | < 0.001 | < 0.001 | < 0.001 |
Non-fatal AMI, n (%) | 126 (0.4) | 33 (0.3) | 43 (0.6) | 26 (0.8) | 0.001 | 0.015 | 0.241 |
Non-fatal stroke, n (%) | 903 (2.7) | 321 (3.2) | 228 (3.1) | 132 (3.9) | < 0.001 | 0.547 | 0.022 |
Heart failure, n (%) | 1,324 (4.0) | 534 (5.3) | 299 (4.0) | 187 (5.5) | < 0.001 | < 0.001 | < 0.001 |
CPO1, n (%) | 9,845 (29.8) | 3,590 (35.9) | 2,503 (33.5) | 1,445 (42.7) | < 0.001 | 0.001 | < 0.001 |
CPO2, n (%) | 10,632 (32.1) | 3,873 (38.8) | 2,674 (35.8) | 1,530 (45.2) | < 0.001 | < 0.001 | < 0.001 |